• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly.

作者信息

Tian Zhuang, Ren Chao, Huo Li, Li Xiao, Wang Yi-Ning, Huang Lun, Tian Ran, Zhang Shu-Yang

机构信息

Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

J Geriatr Cardiol. 2020 Dec 28;17(12):793-796. doi: 10.11909/j.issn.1671-5411.2020.12.010.

DOI:10.11909/j.issn.1671-5411.2020.12.010
PMID:33424949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762698/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/89a0533fa42f/jgc-17-12-793-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/e9ce1cac4510/jgc-17-12-793-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/05274286649d/jgc-17-12-793-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/89a0533fa42f/jgc-17-12-793-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/e9ce1cac4510/jgc-17-12-793-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/05274286649d/jgc-17-12-793-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/7762698/89a0533fa42f/jgc-17-12-793-3.jpg

相似文献

1
Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly.野生型转甲状腺素蛋白淀粉样变性，老年人射血分数保留的心力衰竭不容忽视的一个原因。
J Geriatr Cardiol. 2020 Dec 28;17(12):793-796. doi: 10.11909/j.issn.1671-5411.2020.12.010.
2
A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者中甲状腺转运蛋白淀粉样变患病率的系统评价和荟萃分析。
Am J Cardiovasc Dis. 2022 Jun 15;12(3):102-111. eCollection 2022.
3
Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.心力衰竭伴射血分数保留患者中应用亲骨性放射性示踪剂对转甲状腺素蛋白心脏淀粉样变进行临床表型分析。
Curr Cardiol Rep. 2018 Mar 8;20(4):23. doi: 10.1007/s11886-018-0970-2.
4
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
5
Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?心脏转甲状腺素蛋白源性淀粉样变性：射血分数保留的心力衰竭中的一个新靶点？
Card Fail Rev. 2020 Aug 7;6:e21. doi: 10.15420/cfr.2019.16. eCollection 2020 Mar.
6
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.转甲状腺素蛋白心脏淀粉样变性：发病机制、治疗方法以及在射血分数保留的心力衰竭中的新作用
Clin Med Insights Cardiol. 2015 Jan 5;8(Suppl 1):39-44. doi: 10.4137/CMC.S15719. eCollection 2014.
7
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.与Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性：一例报告
J Med Case Rep. 2018 Dec 16;12(1):370. doi: 10.1186/s13256-018-1931-5.
8
Utility of Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.锝-焦磷酸盐闪烁扫描术在实际临床实践中诊断转甲状腺素蛋白型心脏淀粉样变的效用
Circ Rep. 2019 Jun 14;1(7):277-285. doi: 10.1253/circrep.CR-19-0015.
9
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.转甲状腺素蛋白心脏淀粉样变：诊断与治疗的最新进展。
ESC Heart Fail. 2019 Dec;6(6):1128-1139. doi: 10.1002/ehf2.12518. Epub 2019 Sep 25.
10
Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.65岁以上射血分数保留的心力衰竭患者左心室成像表型的初步研究：淀粉样心肌病的高患病率
Int J Cardiovasc Imaging. 2016 Sep;32(9):1403-1413. doi: 10.1007/s10554-016-0915-z. Epub 2016 May 30.

引用本文的文献

1
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).世界心脏联合会关于转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM）的共识。
Glob Heart. 2023 Oct 26;18(1):59. doi: 10.5334/gh.1262. eCollection 2023.
2
Failure to Confirm Typical Echocardiographic Findings of Cardiac Amyloidosis in an Unresolved Nonischemic Cardiomyopathy Associated With Smoldering Multiple Myeloma: A Case Report.未确诊心脏淀粉样变典型超声心动图表现：与冒烟型多发性骨髓瘤相关的未解决的非缺血性心肌病病例报告
Cureus. 2023 Sep 7;15(9):e44845. doi: 10.7759/cureus.44845. eCollection 2023 Sep.

本文引用的文献

1
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.转甲状腺素蛋白心脏淀粉样变：诊断与治疗的最新进展。
ESC Heart Fail. 2019 Dec;6(6):1128-1139. doi: 10.1002/ehf2.12518. Epub 2019 Sep 25.
2
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议：疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
3
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
心脏转甲状腺素蛋白淀粉样变性的前沿放射性核素成像
J Nucl Cardiol. 2019 Feb;26(1):158-173. doi: 10.1007/s12350-018-01552-4. Epub 2018 Dec 19.
4
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
5
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
6
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
7
Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy.应用二维斑点追踪纵向应变的参数显示来改善轻至中度左心室肥厚的病因诊断。
J Am Soc Echocardiogr. 2014 Aug;27(8):888-95. doi: 10.1016/j.echo.2014.04.015. Epub 2014 May 27.
8
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.射血分数保留的心力衰竭患者的左心室淀粉样变沉积
JACC Heart Fail. 2014 Apr;2(2):113-22. doi: 10.1016/j.jchf.2013.11.004.
9
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.(99m)Tc-焦磷酸盐闪烁显像术鉴别轻链型心脏淀粉样变性与转甲状腺素蛋白相关家族性和老年性心脏淀粉样变性。
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. doi: 10.1161/CIRCIMAGING.112.000132. Epub 2013 Feb 11.
10
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.系统性心脏淀粉样变：3种主要类型的疾病特征与临床病程
Circulation. 2009 Sep 29;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334. Epub 2009 Sep 14.